Welcome to our dedicated page for Scotts Miracle Gr SEC filings (Ticker: SMG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Scotts Miracle-Gro Company (NYSE: SMG) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its operations, governance and financial condition. As an Ohio‑incorporated issuer with common shares listed on the New York Stock Exchange, ScottsMiracle-Gro uses periodic reports and current reports to describe its branded consumer lawn and garden business, indoor and hydroponic growing operations and related financing arrangements.
On this page, you can review core filings such as the annual report on Form 10‑K and quarterly reports on Form 10‑Q, which include segment information for U.S. Consumer, Hawthorne and Other, along with discussions of risk factors, liquidity, capital resources and segment performance. These filings also elaborate on topics referenced in company news releases, such as gross margin trends, leverage, free cash flow and the role of credit facilities and receivables programs in the capital structure.
Current reports on Form 8‑K provide more targeted updates. Recent 8‑K filings describe a Seventh Amended and Restated Credit Agreement establishing senior secured loan facilities, amendments to a master receivables purchase agreement, results of operations for specific quarters and changes to the board of directors and equity award documentation. These filings outline key terms such as leverage and interest coverage covenants, security packages and the use of proceeds for working capital and general corporate purposes.
Definitive proxy statements on Schedule 14A offer detail on corporate governance and executive compensation. ScottsMiracle-Gro’s proxy materials cover board composition, committee responsibilities, director independence, say‑on‑pay proposals, long‑term incentive plan terms, stock ownership guidelines and severance and change‑in‑control arrangements.
This filings page combines real‑time access to new EDGAR submissions with AI‑generated summaries that explain the structure and implications of each document. Users can quickly identify items such as 10‑K and 10‑Q reports, 8‑K current reports, proxy statements and exhibits related to credit agreements or incentive plans, and use the summaries to focus on the sections most relevant to their analysis of SMG.
Hagedorn Partnership, L.P., a director and reported 10% owner of The Scotts Miracle-Gro Company (SMG), reported multiple sales of common stock on 09/05/2025. The Form 4 shows three sale transactions totaling 56,633 shares: 41,979 shares at a weighted average price of $62.73, 11,806 shares at $63.69, and 2,848 shares at $64.52. After these sales the reported beneficial holdings remained above 13.2 million shares as held by the Hagedorn Partnership.
The filing states the shares are held indirectly by the Hagedorn Partnership and names the partnership's general partners, who disclaim beneficial ownership except for pecuniary interest. The Form 4 was signed by an attorney-in-fact on behalf of the partnership on 09/08/2025. Detailed per-trade breakdowns are available upon request per the filing.
The Scotts Miracle-Gro Company (SMG) filed a Form 144 reporting a proposed sale of common stock. The notice lists 56,633 shares to be sold through Merrill on 09/05/2025 with an aggregate market value of $3,586,987. The filing shows these shares were originally acquired on 06/16/1995 as a partnership contribution from Community Fund & General Partnership and paid in stock. It also discloses a sale during the past three months: the Hagedorn Partnership sold 70,000 shares on 08/04/2025 for $4,321,000. The filing includes the seller's representation that they possess no undisclosed material adverse information about the issuer.
Mark J. Scheiwer, who serves as EVP, CFO & CAO of The Scotts Miracle-Gro Company (SMG), reported an open-market purchase of common shares on 09/03/2025. The Form 4 shows he acquired 1,790 common shares at $61.32 per share. After the transaction his reported beneficial ownership is 10,129.6898 shares. The filing was signed on behalf of Mr. Scheiwer by an attorney-in-fact, Kathy L. Uttley, on 09/04/2025.
The Scotts Miracle-Gro Company entered into a Second Amendment to its Master Receivables Purchase Agreement with JPMorgan Chase Bank, N.A., extending the receivables purchase program’s Purchase Termination Date from September 1, 2025 to September 1, 2026. This keeps in place a financing facility that allows certain subsidiaries to sell customer receivables to JPMorgan.
Under the amended agreement, the sellers may sell, and JPMorgan may purchase on an uncommitted, weekly basis, up to $750 million of eligible accounts receivable generated from sales to five specified customers. The facility remains largely non-recourse to the sellers and the Company, aside from defined repurchase and indemnification obligations, which are supported by $75 million of standby letters of credit issued under the Company’s senior secured revolving facility. The Company continues to expect to use proceeds from receivables sales for general corporate purposes.
Christopher J. Hagedorn, EVP & Chief of Staff at The Scotts Miracle-Gro Company (SMG), reported an insider transaction dated 08/25/2025. The Form 4 shows a non-derivative acquisition of 4.1271 common shares at a price of $52.58 per share. Following the reported transaction the filing records 54,059.4168 common shares beneficially owned. The form was signed by an attorney-in-fact on 08/28/2025.
Mark J. Scheiwer, EVP, CFO & CAO of The Scotts Miracle-Gro Company (SMG), reported purchases of the issuer's common stock and phantom stock representing common shares. On 08/25/2025 he acquired 2.8528 common shares at $52.58, leaving him with 8,339.6898 shares directly and 433.874 shares indirectly through a 401(k) plan. On 08/26/2025 he was credited with 4.726 shares of phantom stock (each representing one common share) at a value of $63.04, following which he beneficially owns 1,059.826 phantom-share equivalents. The phantom shares are payable in cash upon termination and may be transferred into alternative investments during employment.
The Form 4 was signed by an attorney-in-fact, Kathy L. Uttley, on behalf of Mr. Scheiwer on 08/28/2025. All information is reported as stated on the form.
James Hagedorn, Chairman & CEO of The Scotts Miracle-Gro Company (SMG), reported insider transactions on Form 4. The filing shows two recent transactions: on 08/25/2025 a non-derivative entry records 38.0373 common shares acquired at $52.58, and on 08/26/2025 the reporting person acquired 1,432.882 units of phantom stock with an indicated price of $63.04 that each represent the right to one common share. The form discloses beneficial ownership across direct and indirect holdings, including 29,413.378 shares via a 401(k) plan and an indirect interest in 997,910 shares held by Hagedorn Partnership, L.P. The phantom stock units are payable in cash following termination of employment and may be transferred into an alternative investment at any time. The filing was signed by an attorney-in-fact on behalf of Mr. Hagedorn.
Nathan Eric Baxter, President and COO and a director of The Scotts Miracle-Gro Company (SMG), reported a purchase on 08/25/2025 of 19.0186 common shares at a price of $52.58 per share. After the transaction the filing shows 50,708.5233 common shares beneficially owned (directly) and 36,993 shares held indirectly through Hagedorn Partnership, L.P., in which Baxter is a general partner. The filing was signed by an attorney-in-fact on 08/28/2025. The disclosure includes an explanatory note that the indirect holdings represent the reporting person’s proportionate interest in partnership-held shares.
Earnest Partners, LLC filed an amended Schedule 13G reporting beneficial ownership of 3,756,898 common shares of The Scotts Miracle-Gro Company, representing 6.5% of the class. The filing lists 2,235,337 shares as sole voting power and 508,050 as shared voting power, with sole dispositive power over all 3,756,898 shares. Earnest Partners states it is filing as an investment adviser and that no single client account holds more than 5% of the class. The filing affirms holdings were acquired in the ordinary course of business.
Scotts Miracle-Gro (SMG) – Form 4 filing for Chairman & CEO James Hagedorn
On 07/25/2025 Hagedorn acquired 34.7283 common shares (Transaction Code “J”, typically dividend reinvestment/other acquisition) at $57.59 per share. His direct holdings increased to 79,728.8776 shares.
He also reports
- 29,413.378 shares held indirectly through the company 401(k) plan
- 1,231,147 shares held indirectly via Hagedorn Partnership, L.P.
The acquisition is immaterial in size (≈ 0.04% of total direct + indirect stake) but reinforces an insider buying, rather than selling, signal.